Amarin Corporation (AMRN) Cross Examination Has Prosecuting Witness Faltering - Jefferies

January 16, 2020 6:36 AM EST Send to a Friend
Jefferies analyst Michael Yee reiterated a Buy rating and $30.00 price target on Amarin Corporation (NASDAQ: AMRN) after day 3 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login